Biopharmaceutical Tubing Market
Biopharmaceutical Tubing Market Size, Share & Industry Analysis, By Material (Silicone, Thermoplastic Elastomer (TPE), Polyvinyl Chloride (PVC), Polyurethane, Others), By Application (Drug Delivery, Dialysis, Sterile Filling, Drainage, Respiratory Care, Others), By End-user (Pharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Research Laboratories, Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031.
Report Highlights:
“Rising at a CAGR of 7.8%, the worldwide biopharmaceutical tubing market is expected to reach USD 7.2 billion by 2031 from USD 3.9 billion in 2022. Over the projection period, North America should lead the market.”
The growing biopharmaceutical sector and rising need for sophisticated drug delivery systems are driving notable increase in the market for biopharmaceutical tubing. The need for high-quality biopharmaceutical tubing is being driven by the increased frequency of chronic illnesses and expanding aging population, which also inspire the need for creative medical equipment and drug delivery systems.
Furthermore improving the performance and adaptability of biopharmaceutical tubing are technical developments in materials science and production techniques, thus driving market expansion.
Market Dynamics:
Market Trend: Increasing acceptance of biopharmaceutical manufacturing single-use systems
Single-use solutions in manufacturing techniques are clearly taking the stage in the biopharmaceutical sector. The need for more flexibility, lower contamination risks, and better cost-effectiveness in biopharmaceutical manufacture fuels this movement. Reduced cleaning and validation needs, less capital investment, and quicker changeover between manufacturing batches are just a few of the benefits of single-use systems—including disposable tubing and components. Consequently, biopharmaceutical businesses are using single-use tubing solutions more and more in their production processes, which increases demand for specialized disposable tubing materials satisfying strict quality and regulatory criteria. With manufacturers concentrating on creating creative single-use tubing solutions that provide improved performance, compatibility, and simplicity of integration into current production systems, this trend is projected to keep influencing the biopharmaceutical tubing market.
Market Driver Growing need for tailored tube solutions
One major force behind market expansion in the biopharmaceutical sector is their increasing need for tailored tubing solutions. Biopharmaceutical businesses need tubing that satisfies certain performance parameters, material qualities, and regulatory norms as they create ever more specialized and sophisticated drug formulations and delivery systems. Factors including the requirement for better medication stability, higher biocompatibility, and best possible drug delivery efficiency drive this need for customizing.
Manufacturers of tubing are reacting to this trend by funding research and development to provide customized solutions for certain application needs. To satisfy the various demands of biopharmaceutical operations, this involves creating tubing with certain diameters, material compositions, surface treatments, and functional qualities. Customized tubing solutions help biopharmaceutical firms to enhance their product performance and production efficiency as well as help manufacturers to set themselves apart in the market.
Strict laws and quality criteria
Strict regulatory rules and quality standards enforced by authorities like the FDA and EMA are major obstacles for the biopharmaceutical tubing industry. These rules are meant to guarantee the effectiveness and safety of biopharmaceutical products as well as the components used in their creation and delivery. Following these guidelines calls for significant outlays of quality control system, documentation, and validation system funds. Manufacturers have to follow Good Manufacturing Practices (GMP) and show uniformity, purity, and biocompatibility of their tube products. The intricacy of these rules may result in lengthier development durations and more expensive new tube goods, therefore perhaps impeding innovation and market entrance. Any changes in regulations might also call for expensive re-valuation procedures and product adjustments. These elements may provide major difficulties for smaller producers and can restrict market access for new competitors, therefore affecting the general competitiveness of the biopharmaceutical tubing industry.
Segment Overview:
Silicone rules the section on materials.
Silicone tubing is highly sought-after in the biopharmaceutical tubing industry because to its exceptional properties and versatility. Silicone has exceptional biocompatibility, flexibility, and resistance to extreme temperatures, making it ideal for use in peristaltic pumps, drug delivery systems, and other critical biopharmaceutical operations.
Its low extractables and leachables profile, combined with its ability to hold its own throughout sterilisation processes, increase its appeal within the industry even more.
Regional Outlook:
Driven by its sophisticated healthcare infrastructure, large expenditures in research & development, and presence of big biopharmaceutical businesses, North America dominates the biopharmaceutical tubing industry. Strong emphasis on innovation in medical equipment and medication delivery systems by the area helps to explain the great need for customized tubing solutions.
Furthermore confirming North America's leadership in the biopharmaceutical tubing industry are the established legal system and early acceptance of innovative technology. Particularly in creating goods for portable and wearable medication delivery systems, the region's focus on customized medicine and the rising trend of home healthcare are predicted to provide fresh prospects for tube makers. Moreover, the aging population in North America and the rising frequency of chronic illnesses fuel need for sophisticated medical treatments, hence growing the market for biopharmaceutical tubing.
Competitive Landscape:
Strong rivalry among important companies defining the biopharmaceutical tubing market emphasizes on innovation, quality, and customizing possibilities. Leading firms are significantly funding research and development to provide cutting-edge materials and production techniques that satisfy changing demands of the biopharmaceutical sector. Strategic alliances and joint projects between research institutes and biopharmaceutical firms and biopharmaceutical companies are becoming more and more frequent, which helps tube manufacturers to create customized solutions and get understanding of new needs.
Larger firms purchasing specialist producers to increase their product ranges and regional presence marks a trend toward consolidation in the industry as well. Companies are also concentrating on creating environmentally friendly tube solutions and adopting green manufacturing techniques to have a competitive advantage as sustainability rises as a major issue.
Major Players:
- Saint-Gobain Performance Plastics
- Nordson Corporation
- Zeus Industrial Products, Inc.
- Freudenberg Medical
- W. L. Gore & Associates, Inc.
- NewAge Industries, Inc.
- Teleflex Incorporated
- Optinova
- Lubrizol Corporation
1. INTRODUCTION
1.1. Market Definition
1.2. Study Scope
1.3. Currency Conversion
1.4. Study Period (2022- 2031)
1.5. Regional Coverage
2. RESEARCH METHODOLOGY
2.1. Primary Research
2.2. Secondary Research
2.3. Company Share Analysis
2.4. Data Triangulation
3. EXECUTIVE SUMMARY
3.1. Global Biopharmaceutical Tubing Market (2018 – 2022)
3.2. Global Biopharmaceutical Tubing Market (2023 – 2031)
3.2.1. Market Segment By Material (2023 – 2031)
3.2.2. Market Segment By Application (2023 – 2031)
3.2.3. Market Segment By End-user (2023 – 2031)
3.2.4. Market Segment By Region (2023 – 2031)
4. MARKET DYNAMICS
4.1. Market Trends
4.1.1. Growing adoption of single-use systems in biopharmaceutical manufacturing
4.1.2. Increasing focus on sustainable and eco-friendly tubing materials
4.1.3. Rising demand for multi-layer tubing for enhanced performance
4.2. Market Drivers
4.2.1. Increasing demand for customized tubing solutions
4.2.2. Expanding biopharmaceutical industry and drug pipeline
4.2.3. Advancements in material science and manufacturing technologies
4.3. Market Restraints
4.3.1. Stringent regulatory requirements and quality standards
4.3.2. High costs associated with specialized tubing materials
4.4. Porter's Five Forces Analysis
4.4.1. Threat of New Entrants
4.4.2. Bargaining Power of Buyers/Consumers
4.4.3. Bargaining Power of Suppliers
4.4.4. Threat of Substitute Products
4.4.5. Intensity of Competitive Rivalry
4.5. Supply Chain Analysis
4.6. Pricing Analysis
4.7. Regulatory Analysis
4.8. Pipeline Analysis
5. BY MATERIAL (MARKET VALUE (US$ MILLION) – 2022-2031*)
5.1. Silicone
5.2. Thermoplastic Elastomer (TPE)
5.3. Polyvinyl Chloride (PVC)
5.4. Polyurethane
5.5. Others
6. BY APPLICATION
6.1. Drug Delivery
6.2. Dialysis
6.3. Sterile Filling
6.4. Drainage
6.5. Respiratory Care
6.6. Others
7. BY END-USER
7.1. Pharmaceutical Companies
7.2. Contract Manufacturing Organizations (CMOs)
7.3. Research Laboratories
7.4. Others
8. GEOGRAPHY
8.1. North America
8.1.1. United States
8.1.2. Canada
8.1.3. Mexico
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Rest of South America
8.3. Europe
8.3.1. Germany
8.3.2. United Kingdom
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Russia
8.3.7. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Australia
8.4.5. South Korea
8.4.6. Rest of Asia-Pacific
8.5. Middle-East
8.5.1. UAE
8.5.2. Saudi Arabia
8.5.3. Turkey
8.5.4. Rest of Middle East
8.6. Africa
8.6.1. South Africa
8.6.2. Egypt
8.6.3. Rest of Africa
9. COMPETITIVE LANDSCAPE
9.1. Key Developments
9.2. Company Market Share Analysis
9.3. Product Benchmarking
10. SWOT ANALYSIS
11. COMPANY PROFILES
11.1. Saint-Gobain Performance Plastics
11.2. Nordson Corporation
11.3. Zeus Industrial Products, Inc.
11.4. Freudenberg Medical
11.5. W. L. Gore & Associates, Inc.
11.6. NewAge Industries, Inc.
11.7. Teleflex Incorporated
11.8. Optinova
11.9. Lubrizol Corporation
11.10. Tekni-Plex, Inc.
11.11. Putnam Plastics Corporation
11.12. Raumedic AG
12. MARKET OPPORTUNITIES
By Material:
- Silicone
- Thermoplastic Elastomer (TPE)
- Polyvinyl Chloride (PVC)
- Polyurethane
- Others
By Application:
- Drug Delivery
- Dialysis
- Sterile Filling
- Drainage
- Respiratory Care
- Others
By End-user:
- Pharmaceutical Companies
- Contract Manufacturing Organizations (CMOs)
- Research Laboratories
- Others
By Region:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Frequently Asked Questions
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511